share_log

MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.

MoonLake Immunotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%)等

SEC announcement ·  02/14 17:04
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息